These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 29258449

  • 1. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C, Nunes AKDS, Magri MC, Dantas BP, Mazza CC, Barone AA, Tengan FM.
    BMC Infect Dis; 2017 Dec 19; 17(1):780. PubMed ID: 29258449
    [Abstract] [Full Text] [Related]

  • 2. The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C.
    Oliveira AIN, Malta FM, Zitelli PMY, Salles APM, Gomes-Gouvea MS, Nastri ACS, Pinho JRR, Carrilho FJ, Oliveira CP, Mendes-Corrêa MC, Pessoa MG, Mazo DF.
    BMC Gastroenterol; 2021 Feb 23; 21(1):81. PubMed ID: 33622266
    [Abstract] [Full Text] [Related]

  • 3. Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.
    Yasui K, Kawaguchi T, Shima T, Mitsuyoshi H, Seki K, Sendo R, Mizuno M, Itoh Y, Matsuda F, Okanoue T.
    J Gastroenterol; 2015 Aug 23; 50(8):887-93. PubMed ID: 25543233
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study.
    Kang Q, Xu J, Luo H, Tan N, Chen H, Cheng R, Pan J, Han Y, Yang Y, Liu D, Xi H, Yu M, Xu X.
    Gene; 2022 Apr 30; 820():146235. PubMed ID: 35143946
    [Abstract] [Full Text] [Related]

  • 5. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.
    Petta S, Maida M, Grimaudo S, Pipitone RM, Macaluso FS, Cabibi D, Cammà C, Di Marco V, Sferrazza S, Craxì A.
    Liver Int; 2016 Feb 30; 36(2):198-204. PubMed ID: 26259026
    [Abstract] [Full Text] [Related]

  • 6. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
    Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S.
    Hepatology; 2011 Mar 30; 53(3):791-9. PubMed ID: 21319195
    [Abstract] [Full Text] [Related]

  • 7. The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis.
    Magri MC, Manchiero C, Prata TVG, Nunes AKDS, Oliveira Junior JS, Dantas BP, Tengan FM.
    Diagn Microbiol Infect Dis; 2020 Jun 30; 97(2):115025. PubMed ID: 32147132
    [Abstract] [Full Text] [Related]

  • 8. Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response.
    Gavril OI, Arhire LI, Gavrilescu O, Dranga M, Barboi O, Gavril RS, Popescu R, Cijevschi Prelipcean C, Trifan AV, Mihai C.
    Medicina (Kaunas); 2021 Oct 24; 57(11):. PubMed ID: 34833371
    [Abstract] [Full Text] [Related]

  • 9. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
    Huang CF, Dai CY, Yeh ML, Huang CI, Tai CM, Hsieh MH, Liang PC, Lin YH, Hsieh MY, Yang HL, Huang JF, Lin ZY, Chen SC, Yu ML, Chuang WL.
    J Hepatol; 2015 Mar 24; 62(3):512-8. PubMed ID: 25457210
    [Abstract] [Full Text] [Related]

  • 10. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
    Scheiner B, Mandorfer M, Schwabl P, Payer BA, Bucsics T, Bota S, Aichelburg MC, Grabmeier-Pfistershammer K, Stättermayer A, Ferenci P, Trauner M, Peck-Radosavljevic M, Reiberger T.
    PLoS One; 2015 Mar 24; 10(11):e0143429. PubMed ID: 26599080
    [Abstract] [Full Text] [Related]

  • 11. PNPLA3 rs738409 Polymorphism Associated with Hepatic Steatosis and Advanced Fibrosis in Patients with Chronic Hepatitis C Virus: A Meta-Analysis.
    Fan JH, Xiang MQ, Li QL, Shi HT, Guo JJ.
    Gut Liver; 2016 May 23; 10(3):456-63. PubMed ID: 26419236
    [Abstract] [Full Text] [Related]

  • 12. Association between PNPLA3[G]/I148M variant, steatosis and fibrosis stage in hepatitis C virus - genetic matters.
    Crisan D, Grigorescu M, Crisan N, Craciun R, Lupsor M, Radu C, Grigorescu MD, Suciu A, Epure F, Avram L, Leach N.
    J Physiol Pharmacol; 2019 Aug 23; 70(4):. PubMed ID: 31642820
    [Abstract] [Full Text] [Related]

  • 13. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
    Nakamura M, Kanda T, Nakamoto S, Miyamura T, Jiang X, Wu S, Yokosuka O.
    PLoS One; 2013 Aug 23; 8(12):e81312. PubMed ID: 24349054
    [Abstract] [Full Text] [Related]

  • 14. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
    Ali M, Yopp A, Gopal P, Beg MS, Zhu H, Lee W, Singal AG.
    Clin Gastroenterol Hepatol; 2016 Feb 23; 14(2):295-300. PubMed ID: 26305067
    [Abstract] [Full Text] [Related]

  • 15. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
    Stättermayer AF, Rutter K, Beinhardt S, Scherzer TM, Stadlmayr A, Hofer H, Wrba F, Steindl-Munda P, Krebs M, Datz C, Trauner M, Ferenci P.
    J Hepatol; 2012 Sep 23; 57(3):492-8. PubMed ID: 22634340
    [Abstract] [Full Text] [Related]

  • 16. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S.
    World J Gastroenterol; 2012 Jun 14; 18(22):2813-20. PubMed ID: 22719190
    [Abstract] [Full Text] [Related]

  • 17. PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.
    Petta S, Vanni E, Bugianesi E, Rosso C, Cabibi D, Cammà C, Di Marco V, Eslam M, Grimaudo S, Macaluso FS, McLeod D, Pipitone RM, Abate ML, Smedile A, George J, Craxì A.
    Aliment Pharmacol Ther; 2015 May 14; 41(10):939-48. PubMed ID: 25801076
    [Abstract] [Full Text] [Related]

  • 18. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
    Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J, Kreipe H, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C.
    Hepatology; 2011 Jul 14; 54(1):60-9. PubMed ID: 21488075
    [Abstract] [Full Text] [Related]

  • 19. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
    Krawczyk M, Rau M, Schattenberg JM, Bantel H, Pathil A, Demir M, Kluwe J, Boettler T, Lammert F, Geier A, NAFLD Clinical Study Group.
    J Lipid Res; 2017 Jan 14; 58(1):247-255. PubMed ID: 27836992
    [Abstract] [Full Text] [Related]

  • 20. The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
    Núñez-Torres R, Macías J, Mancebo M, Frías M, Dolci G, Téllez F, Merino D, Merchante N, Gómez-Mateos J, Guaraldi G, Rivero-Juárez A, Pineda JA, Real LM, HEPAVIR-esteatosis Study Group.
    PLoS One; 2016 Jan 14; 11(12):e0168265. PubMed ID: 27973562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.